Patent · US Active

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

US7449458B2 · kind B2 · utility

73Cited by
33References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 19, 2006
Grant dateNov 11, 2008
Priority date
Expiry dateSep 4, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65742
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds of structural formula shown below, compositions comprising these compounds, intermediates and methods for synthesizing these compounds, and methods for using these compounds in a variety of applications including treatment of autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.